经皮扩张气管切开术中纤维支气管镜监测:FIBERTRACH多中心随机对照试验
FIBERTRACH为西班牙4个内外科ICU开展的多中心、非盲、随机平行组试验,2019年12月至2024年12月纳入442例因长期机械通气行经皮扩张气管切开的成人患者,1:1随机至内镜引导组(221例)与非内镜引导组(221例),均采用单次扩张法并由经验丰富临床医师操作、患者无危险因素。主要终点围术期并发症发生率内镜组25例(11.3%) vs 非内镜组29例(13.1%),95%CI -6.8至10.4,p=0.663。内镜组术中平均峰值吸气压力更高(47.4±17.6 vs 37.05±10.6 cm H2O,95%CI 7.5-13.2,p<0.001),术毕平均PaCO2更高(44.3±8.9 vs 41.5±8.1 mm Hg,95%CI 1.1-4.4,p=0.001)。结论认为常规内镜引导在并发症发生率方面未显示优于非内镜引导。
要点
- 无危险因素、经验丰富操作者单次扩张法经皮扩张气管切开,内镜引导组围术期并发症11.3% vs 非内镜组13.1%,p=0.663,未达统计学显著。
- 内镜引导组术中平均峰值吸气压力47.4±17.6 vs 非内镜组37.05±10.6 cm H2O,内镜组更高(95%CI 7.5-13.2,p<0.001)。
- 内镜引导组术毕平均PaCO2 44.3±8.9 vs 非内镜组41.5±8.1 mm Hg,内镜组更高(95%CI 1.1-4.4,p=0.001)。
- 本研究纳入因长期机械通气行经皮扩张气管切开的成人ICU患者,排除标准及危险因素界定需参照原文。
- 作者结论:常规内镜引导在并发症发生率方面未显示优于非内镜引导。
适用人群与场景
- 成人因长期机械通气在ICU行经皮扩张气管切开的患者。
- 由经验丰富临床医师操作、患者无危险因素,采用单次扩张法。
- 研究在西班牙4个内外科ICU开展,2019年12月至2024年12月入组。
处置流程与药物剂量
- 内镜引导经皮扩张气管切开:采用单次扩张法,由经验丰富临床医师在无危险因素患者中操作。
- 非内镜引导经皮扩张气管切开:采用单次扩张法,由经验丰富临床医师在无危险因素患者中操作。
研究设计与关键结果
- 多中心、非盲、随机平行组试验,意向性分析,西班牙4个内外科ICU,2019年12月至2024年12月,纳入442例,内镜引导组221例 vs 非内镜引导组221例。
- 主要终点围术期并发症:内镜引导组25例(11.3%) vs 非内镜引导组29例(13.1%),95%CI -6.8至10.4,p=0.663。
- 术中平均峰值吸气压力:内镜引导组47.4±17.6 vs 非内镜引导组37.05±10.6 cm H2O,95%CI 7.5-13.2,p<0.001。
- 术毕平均PaCO2:内镜引导组44.3±8.9 vs 非内镜引导组41.5±8.1 mm Hg,95%CI 1.1-4.4,p=0.001。
- 次要终点包括术中气道压力、术后气体交换及出院时全因死亡率。
证据类型、等级与局限
- 证据类型:多中心、非盲、随机平行组试验,意向性分析。
- ClinicalTrials.gov标识:NCT04265625。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在无危险因素、由经验丰富操作者行单次扩张法经皮扩张气管切开的成人ICU患者中,常规内镜引导未显示降低围术期并发症。
- 内镜引导时术中峰值吸气压力及术毕PaCO2更高,需结合原文数据评估。
- 作者结论:常规内镜引导在并发症发生率方面未显示优于非内镜引导。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the prevalence of perioperative complications of endoscopic-guided percutaneous dilatational tracheostomy vs. nonendoscopic-guided percutaneous dilatational tracheostomy.
DESIGN: Multicenter, unblinded, randomized parallel-group trial with an intention-to-treat analysis conducted from December 2019 to December 2024. ClinicalTrials.gov Identifier: NCT04265625.
SETTING: Four medical-surgical ICUs in Spain.
PATIENTS: Adults undergoing tracheostomy for prolonged mechanical ventilation were enrolled.
INTERVENTIONS: Patients were randomized to: 1) endoscopic-guided percutaneous dilatational tracheostomy or 2) nonendoscopic-guided percutaneous dilatational tracheostomy, both performed with the single dilatation method and by experienced clinicians in patients with no risk factors.
MEASUREMENTS AND MAIN RESULTS: The primary endpoint was the prevalence of perioperative complications. The secondary endpoints included airway pressures during the procedure, gas exchange after the procedure and all-cause mortality at hospital discharge. We enrolled 442 patients, 221 patients assigned to each arm. Twenty-five patients (11.3%) in the endoscopic-guided percutaneous dilatational tracheostomy group and 29 (13.1%) in nonendoscopic-guided percutaneous dilatational tracheostomy group had perioperative complications (95% CI, -6.8 to 10.4; p = 0.663). Patients randomized to endoscopic-guided percutaneous dilatational tracheostomy had higher mean peak inspiratory pressure (47.4 ± 17.6 vs. 37.05 ± 10.6 cm H 2 O; 95% CI, 7.5-13.2; p < 0.001) during the procedure and higher mean Pa co2 at the end of the procedure (44.3 ± 8.9 vs. 41.5 ± 8.1 mm Hg; 95% CI, 1.1-4.4; p = 0.001) than nonendoscopic-guided percutaneous dilatational tracheostomy patients.
CONCLUSIONS: In critically ill patients undergoing percutaneous dilatational tracheostomy, the routine use of endoscopic guidance did not demonstrate superiority over procedures performed without endoscopic guidance in terms of complication rates.
参考来源
- Añón JM, Figueira JC, Civantos B, et al. Fiberoptic Bronchoscopy Monitoring During Percutaneous Dilatational Tracheostomy: A Multicenter, Randomized, Controlled Trial. The FIBERTRACH Randomized Clinical Trial. Crit Care Med. 2026. PMID: 41757863. doi:10.1097/CCM.0000000000007078
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。